Home Featured Page 51

Featured

Latest

Q1 2026: Oregon Psilocybin Services Update

Psychedelic Funding Update: Q2 2026

Five Phases, Eight Circuits: Chinese Medicine as a Map for Psychedelic Consciousness

Rachel Turetzky, PhD & Douglas S. Wingate, DTCM: The Eight-Circuit Model, Metaprogramming, and Psychedelic Therapy

Pα+ Psychedelic Bulletin #228: Inside the Lilly-Atai Deal; An Update on the GH-AtaiBeckley Patent Standoff; Field Reacts to FDA’s Guidance; Resilient Readies Resubmission

Intention, Making Space for Integration, and Finding Joy in the Mundane

The Psychedelic News Feed: March 4, 2024 – September 1, 2024

Pα+ Psychedelic Bulletin #173: Upcoming Trial Readouts to Watch; Lykos Prioritises...

Why Did the FDA Reject MDMA-Assisted Therapy for PTSD?

Could Psychedelics Transform How Doctors Treat Chronic Pain?

Finding Your Soul’s Purpose: Harnessing Psychedelic Insights for Professional Growth

How to Create Your Own Psychedelic Integration Circle

Real-World Data Reveals Variability in Access to, and Use of, Spravato

The ‘Nada Effect’: Why Psychedelics Don’t Work for Everyone

Psychedelic Outlaws: Cluster Headaches, Citizen Science, and the Story of ClusterBusters

EDITOR PICKS

Q1 2026: Oregon Psilocybin Services Update

Psychedelic Funding Update: Q2 2026

Five Phases, Eight Circuits: Chinese Medicine as a Map for Psychedelic...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Q1 2026: Oregon Psilocybin Services Update

Psychedelic Funding Update: Q2 2026

Five Phases, Eight Circuits: Chinese Medicine as a Map for Psychedelic Consciousness

Rachel Turetzky, PhD & Douglas S. Wingate, DTCM: The Eight-Circuit Model, Metaprogramming, and Psychedelic Therapy

Pα+ Psychedelic Bulletin #228: Inside the Lilly-Atai Deal; An Update on the GH-AtaiBeckley Patent Standoff; Field Reacts to FDA’s Guidance; Resilient Readies Resubmission

Intention, Making Space for Integration, and Finding Joy in the Mundane

The Psychedelic News Feed: March 4, 2024 – September 1, 2024

Pα+ Psychedelic Bulletin #173: Upcoming Trial Readouts to Watch; Lykos Prioritises...

Why Did the FDA Reject MDMA-Assisted Therapy for PTSD?

Could Psychedelics Transform How Doctors Treat Chronic Pain?

Finding Your Soul’s Purpose: Harnessing Psychedelic Insights for Professional Growth

How to Create Your Own Psychedelic Integration Circle

Real-World Data Reveals Variability in Access to, and Use of, Spravato

The ‘Nada Effect’: Why Psychedelics Don’t Work for Everyone

Psychedelic Outlaws: Cluster Headaches, Citizen Science, and the Story of ClusterBusters

EDITOR PICKS

Q1 2026: Oregon Psilocybin Services Update

Psychedelic Funding Update: Q2 2026

Five Phases, Eight Circuits: Chinese Medicine as a Map for Psychedelic...

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY